Hepatocellular Carcinoma
From the Journals
New biomarker tests could reduce need for liver biopsy
The blood-based tests could expand diagnostic options at health care facilities and facilitate enrollment in NASH clinical trials.
Conference Coverage
Drug combo improves recurrence-free survival after HCC resection
Study shows significant improvement in recurrence-free survival with atezolizumab and bevacizumab combo.